Document is current
Any future updates will be listed below
-
Authors
Dillon, Brendan R. https://orcid.org/0000-0003-2004-3887
Agrawal, Nidhi https://orcid.org/0000-0001-6024-9236
Schwarz, Yair https://orcid.org/0000-0002-5025-0150
Dancel-Manning, Kristen https://orcid.org/0000-0002-8656-1866
Tabarin, Antoine https://orcid.org/0000-0003-1231-3306
Lacroix, André https://orcid.org/0000-0003-4137-3025
Hofland, Leo J. https://orcid.org/0000-0002-4897-2197
Feelders, Richard A. https://orcid.org/0000-0003-2319-391X
- License Information
-
More Information
Article History
Accepted: 30 July 2025
First Online: 15 September 2025
Declarations
:
: No funding was received to assist with the preparation of this manuscript.
: Nidhi Agrawal is on the advisory board for Xeris, Amryt, Camurus, Crinetics, and Novo Nordisk and serves as a principal investigator on research trials for Amryt, Recordati, Ascendis, and Novo Nordisk. Antoine Tabarin has received speaker and board honoraria from Recordati and HRA Pharma. André Lacroix has received research grants and speaker fees from Pfizer Canada and Recordati Canada Rare Diseases, speaker fees from Medunik Canada, and royalties as an editor of the adrenal section of UpToDate and Encyclopedia of Endocrine Diseases and is a co-inventor on a patent for endocrine diseases related to KDM1A for work registered at the Universite Paris–Saclay. Richard A. Feelders has received speaker fees and research grants from Recordati and Corcept. Brendan R. Dillon, Yair Schwarz, Kristen Dancel-Manning, and Leo J. Hofland have no interests to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Brendan R. Dillon, Nidhi Agrawal, Yair Schwarz, Antoine Tabarin, André Lacroix, Leo J. Hofland, and Richard A. Feelders contributed to manuscript conceptualization, literature search, original draft preparation, and review and editing. Kristen Dancel-Manning created the figures using Adobe Illustrator, Adobe Fresco, and Microsoft PowerPoint. All authors read and approved the final manuscript.
